Medical inquiries

Connect with my medical science liaison

Chat live

Available Monday - Friday 9AM - 4:30PM ET

Call me now

Available Monday - Friday 9AM - 7:30PM ET

Email your inquiry

Call 1-800-526-7736

Available Monday - Friday 9AM - 8PM ET

Live video

Available Monday - Friday 9AM - 4:30PM ET

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

UPTRAVI® (selexipag)

Medical Information

+ Save link

UPTRAVI for Injection – Latex

Last Updated: 12/09/2024

SUMMARY

UPTRAVI for Injection

UPTRAVI for injection is not made with natural rubber latex.¹ UPTRAVI for injection contains selexipag and the following inactive ingredients (excipients): glycine, phosphoric acid, polysorbate 20, and sodium hydroxide.² UPTRAVI for injection is supplied in a 10 mL Type I clear glass vial closed by a stopper and tear-off aluminum seal.² The vial stopper is not made with natural rubber latex.³

However, we cannot guarantee that the excipients do not come in contact with natural rubber latex during the manufacturing or packaging process (e.g., latex gloves).

References

Show

1	Data on File. Technical document patient safety and compliance information for selexipag IV 0.5 mg/g. TV-TEC-170697 version 2.0; 25 Jul 2024. Janssen Pharmaceutical Company; 2024.
2	UPTRAVI (selexipag) [Prescribing Information]. Titusville, NJ: Actelion Pharmaceuticals US, Inc, a Janssen Pharmaceutical Company. https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/UPTRAVI-pi.pdf
3	Data on File. Selexipag IV vial. Personal communication with primary container and device discovery; 25 Nov 2024; 2024.